The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pragmatic, single-arm clinical trial of a dose-adjustment algorithm for preventing cytopenia-related delays during FOLFOX chemotherapy.
 
Gabriel A. Brooks
Consulting or Advisory Role - CareCentrix; Ipsen; UnitedHealthcare
Research Funding - Roche/Genentech (Inst)
 
Heather Wright
No Relationships to Disclose
 
Gregory H. Ripple
No Relationships to Disclose
 
Manik A. Amin
No Relationships to Disclose
 
Alexander D. Fuld
No Relationships to Disclose
 
Sivraj Muralikrishnan
No Relationships to Disclose
 
Elizabeth Boutin McGrath
No Relationships to Disclose
 
Maureen G. Stannard
No Relationships to Disclose
 
Lora L. Schofield
No Relationships to Disclose
 
Sierra Lord-Halvorson
No Relationships to Disclose
 
Grace R. Lachance
No Relationships to Disclose
 
Tor D. Tosteson
No Relationships to Disclose
 
Anna N.A. Tosteson
No Relationships to Disclose
 
Konstantin H. Dragnev
Research Funding - Amgen (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Io Therapeutics (Inst); Lilly (Inst); Merck (Inst); Molecular Templates (Inst); Novartis (Inst); PharmaMar (Inst); Roche/Genentech (Inst)
 
Kathryn Cunningham Hourdequin
Stock and Other Ownership Interests - Johnson & Johnson/Janssen (I); United Health Group (I)
Research Funding - Inspirna (Inst)
Patents, Royalties, Other Intellectual Property - Receive royalties through the University of Minnesota for MNRead low vision eye chart (Inst)